▶ 調査レポート

パーキンソン病治療薬の世界市場2017

• 英文タイトル:Global Parkinson's Disease Therapeutics Market Size, Status and Forecast 2022

QYResearchが調査・発行した産業分析レポートです。パーキンソン病治療薬の世界市場2017 / Global Parkinson's Disease Therapeutics Market Size, Status and Forecast 2022 / A04108357資料のイメージです。• レポートコード:A04108357
• 出版社/出版日:QYResearch / 2017年3月8日
• レポート形態:英文、PDF、110ページ
• 納品方法:Eメール(受注後2~3営業日)
• 産業分類:医療・製薬・バイオ
• 販売価格(消費税別)
  Single User¥349,800 (USD3,300)▷ お問い合わせ
  Enterprise¥699,600 (USD6,600)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
本調査レポートでは、パーキンソン病治療薬の世界市場について調査・分析し、パーキンソン病治療薬のメーカー別販売量、市場シェア分析、種類別販売分析、用途別販売分析、地域別販売分析(アメリカ、中国、ヨーロッパ、日本、東南アジア、インド)、価格動向、企業動向、パーキンソン病治療薬産業チェーン分析、世界市場規模予測などを含め、以下の構成でお届けいたします。(※Sales:パーキンソン病治療薬の販売量、Revenue:パーキンソン病治療薬の売上高)

・パーキンソン病治療薬市場概要
・パーキンソン病治療薬のメーカー別販売量・メーカー別シェア
・パーキンソン病治療薬の世界市場:種類別販売量・市場シェア
・パーキンソン病治療薬の世界市場:用途別販売量・市場シェア
・パーキンソン病治療薬の世界市場:地域別販売量・市場シェア
・パーキンソン病治療薬のアメリカ市場規模
・パーキンソン病治療薬の中国市場規模
・パーキンソン病治療薬のヨーロッパ市場規模
・パーキンソン病治療薬の日本市場規模
・パーキンソン病治療薬の東南アジア市場規模
・パーキンソン病治療薬のインド市場規模
・パーキンソン病治療薬のメーカー別分析(企業概要、事業概要、商品概要、収益、価格等)
・パーキンソン病治療薬のコスト分析・価格動向
・パーキンソン病治療薬の産業チェーン(サプライチェーン分析)
・パーキンソン病治療薬のマーケティング戦略・販売チャネル、流通業者
・パーキンソン病治療薬市場への影響要因分析
・パーキンソン病治療薬の世界市場予測
・パーキンソン病治療薬のアメリカ市場予測
・パーキンソン病治療薬の中国市場予測
・パーキンソン病治療薬のヨーロッパ市場予測
・パーキンソン病治療薬の日本市場予測
・パーキンソン病治療薬の東南アジア市場予測
・パーキンソン病治療薬のインド市場予測
・パーキンソン病治療薬の種類別世界市場予測
・パーキンソン病治療薬の用途別世界市場予測
...

This report studies the global Parkinson’s Disease Therapeutics market, analyzes and researches the Parkinson’s Disease Therapeutics development status and forecast in United States, EU, Japan, China, India and Southeast Asia. This report focuses on the top players in global market, like
GlaxoSmithKline
Salix Pharmaceuticals
Mpax Laboratories
Teva Pharmaceutical Industries
Novartis AG
Orion Corporation
Mylan NV
Par Pharmaceutical
Cipla
Daiichi Sankyo
Apotex
Wockhardt Limited
GSK
Novartis
Boehringer Ingelheim
Abbvie
Merck
Akorn
Astellas Pharma
Desitin Arzneimittel
Endo Pharmaceuticals
F Hoffmann-La Roche
H Lundbeck
Kyowa Hakko Kirin Pharma
Stada Arzneimittel
Valeant
Apokyn

Market segment by Regions/Countries, this report covers
United States
EU
Japan
China
India
Southeast Asia

Market segment by Type, Parkinson’s Disease Therapeutics can be split into
Medications Therapeutics
Medical Devices Therapeutics

Market segment by Application, Parkinson’s Disease Therapeutics can be split into
Hospitals
Clinics
Homecare Settings
Other

レポート目次

Table of Contents

Global Parkinson’s Disease Therapeutics Market Size, Status and Forecast 2022
1 Industry Overview of Parkinson’s Disease Therapeutics
1.1 Parkinson’s Disease Therapeutics Market Overview
1.1.1 Parkinson’s Disease Therapeutics Product Scope
1.1.2 Market Status and Outlook
1.2 Global Parkinson’s Disease Therapeutics Market Size and Analysis by Regions
1.2.1 United States
1.2.2 EU
1.2.3 Japan
1.2.4 China
1.2.5 India
1.2.6 Southeast Asia
1.3 Parkinson’s Disease Therapeutics Market by Type
1.3.1 Medications Therapeutics
1.3.2 Medical Devices Therapeutics
1.4 Parkinson’s Disease Therapeutics Market by End Users/Application
1.4.1 Hospitals
1.4.2 Clinics
1.4.3 Homecare Settings
1.4.4 Other

2 Global Parkinson’s Disease Therapeutics Competition Analysis by Players
2.1 Parkinson’s Disease Therapeutics Market Size (Value) by Players (2016 and 2017)
2.2 Competitive Status and Trend
2.2.1 Market Concentration Rate
2.2.2 Product/Service Differences
2.2.3 New Entrants
2.2.4 The Technology Trends in Future

3 Company (Top Players) Profiles
3.1 GlaxoSmithKline
3.1.1 Company Profile
3.1.2 Main Business/Business Overview
3.1.3 Products, Services and Solutions
3.1.4 Parkinson’s Disease Therapeutics Revenue (Value) (2012-2017)
3.1.5 Recent Developments
3.2 Salix Pharmaceuticals
3.2.1 Company Profile
3.2.2 Main Business/Business Overview
3.2.3 Products, Services and Solutions
3.2.4 Parkinson’s Disease Therapeutics Revenue (Value) (2012-2017)
3.2.5 Recent Developments
3.3 Mpax Laboratories
3.3.1 Company Profile
3.3.2 Main Business/Business Overview
3.3.3 Products, Services and Solutions
3.3.4 Parkinson’s Disease Therapeutics Revenue (Value) (2012-2017)
3.3.5 Recent Developments
3.4 Teva Pharmaceutical Industries
3.4.1 Company Profile
3.4.2 Main Business/Business Overview
3.4.3 Products, Services and Solutions
3.4.4 Parkinson’s Disease Therapeutics Revenue (Value) (2012-2017)
3.4.5 Recent Developments
3.5 Novartis AG
3.5.1 Company Profile
3.5.2 Main Business/Business Overview
3.5.3 Products, Services and Solutions
3.5.4 Parkinson’s Disease Therapeutics Revenue (Value) (2012-2017)
3.5.5 Recent Developments
3.6 Orion Corporation
3.6.1 Company Profile
3.6.2 Main Business/Business Overview
3.6.3 Products, Services and Solutions
3.6.4 Parkinson’s Disease Therapeutics Revenue (Value) (2012-2017)
3.6.5 Recent Developments
3.7 Mylan NV
3.7.1 Company Profile
3.7.2 Main Business/Business Overview
3.7.3 Products, Services and Solutions
3.7.4 Parkinson’s Disease Therapeutics Revenue (Value) (2012-2017)
3.7.5 Recent Developments
3.8 Par Pharmaceutical
3.8.1 Company Profile
3.8.2 Main Business/Business Overview
3.8.3 Products, Services and Solutions
3.8.4 Parkinson’s Disease Therapeutics Revenue (Value) (2012-2017)
3.8.5 Recent Developments
3.9 Cipla
3.9.1 Company Profile
3.9.2 Main Business/Business Overview
3.9.3 Products, Services and Solutions
3.9.4 Parkinson’s Disease Therapeutics Revenue (Value) (2012-2017)
3.9.5 Recent Developments
3.10 Daiichi Sankyo
3.10.1 Company Profile
3.10.2 Main Business/Business Overview
3.10.3 Products, Services and Solutions
3.10.4 Parkinson’s Disease Therapeutics Revenue (Value) (2012-2017)
3.10.5 Recent Developments
3.11 Apotex
3.12 Wockhardt Limited
3.13 GSK
3.14 Novartis
3.15 Boehringer Ingelheim
3.16 Abbvie
3.17 Merck
3.18 Akorn
3.19 Astellas Pharma
3.20 Desitin Arzneimittel
3.21 Endo Pharmaceuticals
3.22 F Hoffmann-La Roche
3.23 H Lundbeck
3.24 Kyowa Hakko Kirin Pharma
3.25 Stada Arzneimittel
3.26 Valeant
3.27 Apokyn

4 Global Parkinson’s Disease Therapeutics Market Size by Type and Application (2012-2017)
4.1 Global Parkinson’s Disease Therapeutics Market Size by Type (2012-2017)
4.2 Global Parkinson’s Disease Therapeutics Market Size by Application (2012-2017)
4.3 Potential Application of Parkinson’s Disease Therapeutics in Future
4.4 Top Consumer/End Users of Parkinson’s Disease Therapeutics

5 United States Parkinson’s Disease Therapeutics Development Status and Outlook
5.1 United States Parkinson’s Disease Therapeutics Market Size (2012-2017)
5.2 United States Parkinson’s Disease Therapeutics Market Size and Market Share by Players (2016 and 2017)

6 EU Parkinson’s Disease Therapeutics Development Status and Outlook
6.1 EU Parkinson’s Disease Therapeutics Market Size (2012-2017)
6.2 EU Parkinson’s Disease Therapeutics Market Size and Market Share by Players (2016 and 2017)

7 Japan Parkinson’s Disease Therapeutics Development Status and Outlook
7.1 Japan Parkinson’s Disease Therapeutics Market Size (2012-2017)
7.2 Japan Parkinson’s Disease Therapeutics Market Size and Market Share by Players (2016 and 2017)

8 China Parkinson’s Disease Therapeutics Development Status and Outlook
8.1 China Parkinson’s Disease Therapeutics Market Size (2012-2017)
8.2 China Parkinson’s Disease Therapeutics Market Size and Market Share by Players (2016 and 2017)

9 India Parkinson’s Disease Therapeutics Development Status and Outlook
9.1 India Parkinson’s Disease Therapeutics Market Size (2012-2017)
9.2 India Parkinson’s Disease Therapeutics Market Size and Market Share by Players (2016 and 2017)

10 Southeast Asia Parkinson’s Disease Therapeutics Development Status and Outlook
10.1 Southeast Asia Parkinson’s Disease Therapeutics Market Size (2012-2017)
10.2 Southeast Asia Parkinson’s Disease Therapeutics Market Size and Market Share by Players (2016 and 2017)

11 Market Forecast by Regions, Type and Application (2017-2022)
11.1 Global Parkinson’s Disease Therapeutics Market Size (Value) by Regions (2017-2022)
11.1.1 United States Parkinson’s Disease Therapeutics Revenue and Growth Rate (2017-2022)
11.1.2 EU Parkinson’s Disease Therapeutics Revenue and Growth Rate (2017-2022)
11.1.3 Japan Parkinson’s Disease Therapeutics Revenue and Growth Rate (2017-2022)
11.1.4 China Parkinson’s Disease Therapeutics Revenue and Growth Rate (2017-2022)
11.1.5 India Parkinson’s Disease Therapeutics Revenue and Growth Rate (2017-2022)
11.1.6 Southeast Asia Parkinson’s Disease Therapeutics Revenue and Growth Rate (2017-2022)
11.2 Global Parkinson’s Disease Therapeutics Market Size (Value) by Type (2017-2022)
11.3 Global Parkinson’s Disease Therapeutics Market Size by Application (2017-2022)

12 Parkinson’s Disease Therapeutics Market Dynamics
12.1 Parkinson’s Disease Therapeutics Market Opportunities
12.2 Parkinson’s Disease Therapeutics Challenge and Risk
12.2.1 Competition from Opponents
12.2.2 Downside Risks of Economy
12.3 Parkinson’s Disease Therapeutics Market Constraints and Threat
12.3.1 Threat from Substitute
12.3.2 Government Policy
12.3.3 Technology Risks
12.4 Parkinson’s Disease Therapeutics Market Driving Force
12.4.1 Growing Demand from Emerging Markets
12.4.2 Potential Application

13 Market Effect Factors Analysis
13.1 Technology Progress/Risk
13.1.1 Substitutes
13.1.2 Technology Progress in Related Industry
13.2 Consumer Needs Trend/Customer Preference
13.3 External Environmental Change
13.3.1 Economic Fluctuations
13.3.2 Other Risk Factors

14 Research Finding/Conclusion

15 Appendix
Methodology
Analyst Introduction
Data Source

List of Tables and Figures

Figure Parkinson's Disease Therapeutics Product Scope
Figure Global Parkinson's Disease Therapeutics Market Size (Million USD) (2012-2017)
Table Global Parkinson's Disease Therapeutics Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Figure Global Parkinson's Disease Therapeutics Market Share by Regions in 2016
Figure United States Parkinson's Disease Therapeutics Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Figure EU Parkinson's Disease Therapeutics Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Figure Japan Parkinson's Disease Therapeutics Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Figure China Parkinson's Disease Therapeutics Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Figure India Parkinson's Disease Therapeutics Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Figure Southeast Asia Parkinson's Disease Therapeutics Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Figure Global Parkinson's Disease Therapeutics Market Share by Type in 2016
Figure Medications Therapeutics Market Size (Million USD) and Growth Rate (2012-2017)
Figure Medical Devices Therapeutics Market Size (Million USD) and Growth Rate (2012-2017)
Figure Global Parkinson's Disease Therapeutics Market Share by Application in 2016
Figure Parkinson's Disease Therapeutics Market Size (Million USD) and Growth Rate in Hospitals (2012-2017)
Figure Parkinson's Disease Therapeutics Market Size (Million USD) and Growth Rate in Clinics (2012-2017)
Figure Parkinson's Disease Therapeutics Market Size (Million USD) and Growth Rate in Homecare Settings (2012-2017)
Figure Parkinson's Disease Therapeutics Market Size (Million USD) and Growth Rate in Other (2012-2017)
Table Parkinson's Disease Therapeutics Market Size (Million USD) by Players (2016 and 2017)
Figure Parkinson's Disease Therapeutics Market Size Share by Players in 2016
Figure Parkinson's Disease Therapeutics Market Size Share by Players in 2017
Table GlaxoSmithKline Basic Information List
Table Parkinson's Disease Therapeutics Business Revenue (Million USD) of GlaxoSmithKline (2012-2017)
Figure GlaxoSmithKline Parkinson's Disease Therapeutics Business Revenue Market Share in 2016
Table Salix Pharmaceuticals Basic Information List
Table Parkinson's Disease Therapeutics Business Revenue (Million USD) of Salix Pharmaceuticals (2012-2017)
Figure Salix Pharmaceuticals Parkinson's Disease Therapeutics Business Revenue Market Share in 2016
Table Mpax Laboratories Basic Information List
Table Parkinson's Disease Therapeutics Business Revenue (Million USD) of Mpax Laboratories (2012-2017)
Figure Mpax Laboratories Parkinson's Disease Therapeutics Business Revenue Market Share in 2016
Table Teva Pharmaceutical Industries Basic Information List
Table Parkinson's Disease Therapeutics Business Revenue (Million USD) of Teva Pharmaceutical Industries (2012-2017)
Figure Teva Pharmaceutical Industries Parkinson's Disease Therapeutics Business Revenue Market Share in 2016
Table Novartis AG Basic Information List
Table Parkinson's Disease Therapeutics Business Revenue (Million USD) of Novartis AG (2012-2017)
Figure Novartis AG Parkinson's Disease Therapeutics Business Revenue Market Share in 2016
Table Orion Corporation Basic Information List
Table Parkinson's Disease Therapeutics Business Revenue (Million USD) of Orion Corporation (2012-2017)
Figure Orion Corporation Parkinson's Disease Therapeutics Business Revenue Market Share in 2016
Table Mylan NV Basic Information List
Table Parkinson's Disease Therapeutics Business Revenue (Million USD) of Mylan NV (2012-2017)
Figure Mylan NV Parkinson's Disease Therapeutics Business Revenue Market Share in 2016
Table Par Pharmaceutical Basic Information List
Table Parkinson's Disease Therapeutics Business Revenue (Million USD) of Par Pharmaceutical (2012-2017)
Figure Par Pharmaceutical Parkinson's Disease Therapeutics Business Revenue Market Share in 2016
Table Cipla Basic Information List
Table Parkinson's Disease Therapeutics Business Revenue (Million USD) of Cipla (2012-2017)
Figure Cipla Parkinson's Disease Therapeutics Business Revenue Market Share in 2016
Table Daiichi Sankyo Basic Information List
Table Parkinson's Disease Therapeutics Business Revenue (Million USD) of Daiichi Sankyo (2012-2017)
Figure Daiichi Sankyo Parkinson's Disease Therapeutics Business Revenue Market Share in 2016
Table Apotex Basic Information List
Table Parkinson's Disease Therapeutics Business Revenue (Million USD) of Apotex (2012-2017)
Figure Apotex Parkinson's Disease Therapeutics Business Revenue Market Share in 2016
Table Wockhardt Limited Basic Information List
Table Parkinson's Disease Therapeutics Business Revenue (Million USD) of Wockhardt Limited (2012-2017)
Figure Wockhardt Limited Parkinson's Disease Therapeutics Business Revenue Market Share in 2016
Table GSK Basic Information List
Table Parkinson's Disease Therapeutics Business Revenue (Million USD) of GSK (2012-2017)
Figure GSK Parkinson's Disease Therapeutics Business Revenue Market Share in 2016
Table Novartis Basic Information List
Table Parkinson's Disease Therapeutics Business Revenue (Million USD) of Novartis (2012-2017)
Figure Novartis Parkinson's Disease Therapeutics Business Revenue Market Share in 2016
Table Boehringer Ingelheim Basic Information List
Table Parkinson's Disease Therapeutics Business Revenue (Million USD) of Boehringer Ingelheim (2012-2017)
Figure Boehringer Ingelheim Parkinson's Disease Therapeutics Business Revenue Market Share in 2016
Table Abbvie Basic Information List
Table Parkinson's Disease Therapeutics Business Revenue (Million USD) of Abbvie (2012-2017)
Figure Abbvie Parkinson's Disease Therapeutics Business Revenue Market Share in 2016
Table Merck Basic Information List
Table Parkinson's Disease Therapeutics Business Revenue (Million USD) of Merck (2012-2017)
Figure Merck Parkinson's Disease Therapeutics Business Revenue Market Share in 2016
Table Akorn Basic Information List
Table Parkinson's Disease Therapeutics Business Revenue (Million USD) of Akorn (2012-2017)
Figure Akorn Parkinson's Disease Therapeutics Business Revenue Market Share in 2016
Table Astellas Pharma Basic Information List
Table Parkinson's Disease Therapeutics Business Revenue (Million USD) of Astellas Pharma (2012-2017)
Figure Astellas Pharma Parkinson's Disease Therapeutics Business Revenue Market Share in 2016
Table Desitin Arzneimittel Basic Information List
Table Parkinson's Disease Therapeutics Business Revenue (Million USD) of Desitin Arzneimittel (2012-2017)
Figure Desitin Arzneimittel Parkinson's Disease Therapeutics Business Revenue Market Share in 2016
Table Endo Pharmaceuticals Basic Information List
Table Parkinson's Disease Therapeutics Business Revenue (Million USD) of Endo Pharmaceuticals (2012-2017)
Figure Endo Pharmaceuticals Parkinson's Disease Therapeutics Business Revenue Market Share in 2016
Table F Hoffmann-La Roche Basic Information List
Table Parkinson's Disease Therapeutics Business Revenue (Million USD) of F Hoffmann-La Roche (2012-2017)
Figure F Hoffmann-La Roche Parkinson's Disease Therapeutics Business Revenue Market Share in 2016
Table H Lundbeck Basic Information List
Table Parkinson's Disease Therapeutics Business Revenue (Million USD) of H Lundbeck (2012-2017)
Figure H Lundbeck Parkinson's Disease Therapeutics Business Revenue Market Share in 2016
Table Kyowa Hakko Kirin Pharma Basic Information List
Table Parkinson's Disease Therapeutics Business Revenue (Million USD) of Kyowa Hakko Kirin Pharma (2012-2017)
Figure Kyowa Hakko Kirin Pharma Parkinson's Disease Therapeutics Business Revenue Market Share in 2016
Table Stada Arzneimittel Basic Information List
Table Parkinson's Disease Therapeutics Business Revenue (Million USD) of Stada Arzneimittel (2012-2017)
Figure Stada Arzneimittel Parkinson's Disease Therapeutics Business Revenue Market Share in 2016
Table Valeant Basic Information List
Table Parkinson's Disease Therapeutics Business Revenue (Million USD) of Valeant (2012-2017)
Figure Valeant Parkinson's Disease Therapeutics Business Revenue Market Share in 2016
Table Apokyn Basic Information List
Table Parkinson's Disease Therapeutics Business Revenue (Million USD) of Apokyn (2012-2017)
Figure Apokyn Parkinson's Disease Therapeutics Business Revenue Market Share in 2016
Table Global Parkinson's Disease Therapeutics Market Size (Million USD) by Type (2012-2017)
Figure Global Parkinson's Disease Therapeutics Market Size Share by Type in 2012
Figure Global Parkinson's Disease Therapeutics Market Size Share by Type in 2013
Figure Global Parkinson's Disease Therapeutics Market Size Share by Type in 2014
Figure Global Parkinson's Disease Therapeutics Market Size Share by Type in 2015
Figure Global Parkinson's Disease Therapeutics Market Size Share by Type in 2016
Figure Global Parkinson's Disease Therapeutics Market Size Share by Type in 2017
Table Global Parkinson's Disease Therapeutics Market Size (Million USD) by Application (2012-2017)
Figure Global Parkinson's Disease Therapeutics Market Size (Million USD) by Application in 2012
Figure Global Parkinson's Disease Therapeutics Market Size (Million USD) by Application in 2013
Figure Global Parkinson's Disease Therapeutics Market Size (Million USD) by Application in 2014
Figure Global Parkinson's Disease Therapeutics Market Size (Million USD) by Application in 2015
Figure Global Parkinson's Disease Therapeutics Market Size (Million USD) by Application in 2016
Figure Global Parkinson's Disease Therapeutics Market Size (Million USD) by Application in 2017
Table Top Consumer/End Users of Parkinson's Disease Therapeutics
Figure United States Parkinson's Disease Therapeutics Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Table United States Parkinson's Disease Therapeutics Market Size (Million USD) by Players (2012-2017)
Figure United States Parkinson's Disease Therapeutics Market Size Share by Players in 2016
Figure United States Parkinson's Disease Therapeutics Market Size Share by Players in 2017
Figure EU Parkinson's Disease Therapeutics Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Table EU Parkinson's Disease Therapeutics Market Size (Million USD) by Players (2012-2017)
Figure EU Parkinson's Disease Therapeutics Market Size Share by Players in 2016
Figure EU Parkinson's Disease Therapeutics Market Size Share by Players in 2017
Figure Japan Parkinson's Disease Therapeutics Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Table Japan Parkinson's Disease Therapeutics Market Size (Million USD) by Players (2012-2017)
Figure Japan Parkinson's Disease Therapeutics Market Size Share by Players in 2016
Figure Japan Parkinson's Disease Therapeutics Market Size Share by Players in 2017
Figure China Parkinson's Disease Therapeutics Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Table China Parkinson's Disease Therapeutics Market Size (Million USD) by Players (2012-2017)
Figure China Parkinson's Disease Therapeutics Market Size Share by Players in 2016
Figure China Parkinson's Disease Therapeutics Market Size Share by Players in 2017
Figure India Parkinson's Disease Therapeutics Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Table India Parkinson's Disease Therapeutics Market Size (Million USD) by Players (2012-2017)
Figure India Parkinson's Disease Therapeutics Market Size Share by Players in 2016
Figure India Parkinson's Disease Therapeutics Market Size Share by Players in 2017
Figure Southeast Asia Parkinson's Disease Therapeutics Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Table Southeast Asia Parkinson's Disease Therapeutics Market Size (Million USD) by Players (2012-2017)
Figure Southeast Asia Parkinson's Disease Therapeutics Market Size Share by Players in 2016
Figure Southeast Asia Parkinson's Disease Therapeutics Market Size Share by Players in 2017
Figure Global Parkinson's Disease Therapeutics Market Size (Million USD) by Regions (2017-2022)
Table Global Parkinson's Disease Therapeutics Market Size (Million USD) by Regions (2017-2022)
Figure Global Parkinson's Disease Therapeutics Market Size Share by Regions in 2017
Figure Global Parkinson's Disease Therapeutics Market Size Share by Regions in 2022
Figure United States Parkinson's Disease Therapeutics Revenue (Million USD) and Growth Rate (2017-2022)
Figure EU Parkinson's Disease Therapeutics Revenue (Million USD) and Growth Rate (2017-2022)
Figure Japan Parkinson's Disease Therapeutics Revenue (Million USD) and Growth Rate (2017-2022)
Figure China Parkinson's Disease Therapeutics Revenue (Million USD) and Growth Rate (2017-2022)
Figure India Parkinson's Disease Therapeutics Revenue (Million USD) and Growth Rate (2017-2022)
Figure Southeast Asia Parkinson's Disease Therapeutics Revenue (Million USD) and Growth Rate (2017-2022)
Table Global Parkinson's Disease Therapeutics Market Size (Million USD) by Type (2017-2022)
Figure Global Parkinson's Disease Therapeutics Market Size Share by Type in 2017
Figure Global Parkinson's Disease Therapeutics Market Size Share by Type in 2022
Table Global Parkinson's Disease Therapeutics Market Size (Million USD) by Application (2017-2022)
Figure Global Parkinson's Disease Therapeutics Market Size (Million USD) by Application in 2017
Figure Global Parkinson's Disease Therapeutics Market Size (Million USD) by Application in 2022